DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Hold” at Jefferies Financial Group

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities researchers at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Thursday, Marketbeat.com reports. They currently have a $20.00 target price on the medical instruments supplier’s stock, down from their previous target price of $30.00. Jefferies Financial Group’s target price would indicate a potential upside of 3.31% from the company’s previous close.

XRAY has been the subject of several other research reports. UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Morgan Stanley reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Ten investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $26.67.

DENTSPLY SIRONA Stock Up 2.1 %

Shares of NASDAQ:XRAY opened at $19.36 on Thursday. The firm’s 50 day moving average price is $18.98 and its 200 day moving average price is $22.74. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of -9.35, a price-to-earnings-growth ratio of 1.77 and a beta of 0.96. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $36.63. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the company earned $0.49 earnings per share. As a group, equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently bought and sold shares of the company. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth $27,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares during the period. Kennebec Savings Bank acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth $35,000. Finally, Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth $42,000. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.